Research
Accuracy of a Novel Non-Invasive Technology Based EZSCAN System for the Diagnosis of Diabetes Mellitus in Chinese
Diabetology & Metabolic Syndrome 2011, 3:36 doi:10.1186/1758-5996-3-36
Published: 22 December 2011Abstract (provisional)
Background
A new simple technique based on iontophoresis technology (EZSCAN, Impeto Medical, Paris, France) has recently been developed for the screening of diabetes. In the present study, we investigated the accuracy of this system for the diagnosis of diabetes mellitus in Chinese.
Methods
We performed the EZSCAN test in diabetic and non-diabetic subjects. EZSCAN measures electrochemical conductance (EC) at forehead, hands and feet, and derives a diabetes index with a value ranging from 0 to 100. Diabetes mellitus was defined as a plasma glucose concentration of at least 7 mmol/l at fasting or 11.1 mmol/l at 2 hours after glucose load, or as the use of antidiabetic drugs.
Results
The 195 study participants (51% men, mean age 52 years) included 75 diabetic patients (use of antidiabetic drugs 81%) and 120 non-diabetic subjects. EC (micro Siemens, muSi) was significantly (P<0.001) lower in diabetic patients at the hands (44 vs. 61) and feet (51 vs. 69) locations, but not at the forehead (15 vs. 17, P=0.39). When a diabetes index of 40 (suggested by the manufacturer) was used as the threshold, the sensitivity and specificity for the diagnosis of diabetes mellitus was 85% and 64%, respectively. In 80 patients who underwent an oral glucose tolerance test, EC at hands and feet and the diabetes index were significantly (P<0.001) associated with both 2-hour post-load plasma glucose and serum glycosylated haemoglobin.
Conclusions
EZSCAN might be useful in screening diabetes mellitus with reasonable sensitivity and specificity.